VANCOUVER, BC & TORONTO, ON-Every day, 27 Canadians receive a brain tumour diagnosis. With over 120 different types, finding the best treatment can be an overwhelming, frightening process for patients and their families. Equally as overwhelming, physicians must carefully consider whether surgical intervention is the best course of action since a tumour’s location may have profound impact upon the patient’s quality of life after surgery.
On this front, Synaptive Medical Inc., a Toronto-based medical device and technology company, believes its innovative BrightMatter™ technology, which integrates imaging, surgical planning, and robotic visualization can help address these patient and physician concerns. Count Vancouver General Hospital among the first to buy into the promise of the technology, becoming the first Canadian hospital to have it installed.
“Some tumours are inoperable because of their location in the brain and their impact on motor, language and other key functions,” explains Dr. Brian Toyota, head of Neurosurgery for Vancouver General Hospital. “With BrightMatter’s planning and advanced visualization capabilities, we hope to provide additional treatment options to patients to improve their quality of life and longevity.”
As a Canadian company proudly headquartered in Toronto, having its first Canadian clinical partner is a huge milestone for Synaptive adds Cameron Piron, co-founder and president of the company.
“Canadian surgeons and researchers have played an integral part in our product development, but Vancouver General Hospital will be the first location where BrightMatter technology is available to Canadian patients,” he said. “We look forward to deepening our existing collaborations with Dr. Toyota and his team.”
BrightMatter uses an imaging method called diffusion tensor imaging, or DTI, that helps visualize MRI images of the entire brain’s pathways. This allows physicians to consider approaches for navigating around critical structures in neurological surgery and to see relevant details in the clinical image that can’t be seen with either the naked eye or a standard MRI. With the technology, such details are updated in real time as the surgeon moves their tools. This additional information may allow access to brain locations previously deemed inoperable.
To learn more about the technology, check out the video below.